International / International
Americas / Americas
Brazil / Brasil
Canada / Canada
Latin America / Latinoamérica
Europe / Europe
Austria / Österreich
Belgium (Flemish) / België
Bosnia and Herzegovina / Босна и Херцеговина
Bulgaria / България
Croatia / Hrvatska
Czech Republic & Slovakia / Česká republika & Slovensko
Finland / Suomi
France / France
Germany / Deutschland
Greece / ΕΛΛΑΔΑ
Italy / Italia
Netherlands / Nederland
Nordic / Nordic
Poland / Polska
Romania & Moldova / România & Moldova
Russia / Россия
Slovenia / Slovenija
Serbia & Montenegro / Србија и Црна Гора
Spain / España
Switzerland / Schweiz
Turkey / Türkiye
UK & Ireland / UK & Ireland
Asia Pacific / Asia Pacific
China / 中国
India / भारत गणराज्य
Japan / 日本
Pakistan / Pākistān
Middle East & Africa / Middle East & Africa
Algeria / الجزائر
Iran / ایران
Middle East / Middle East
On Demand Webinar
Neuer Ansatz in der Implantattherapie von Patienten unter Antikoagulant-Medikation (DOAC)Stefan Grümer M.Sc.
BIOLASE
Events
Browse our online event calender to see events organized by BIOLASE and tradeshows which BIOLASE will be attending.
Everything BIOLASE
NewsView All
May 20, 2021 | Events, Interviews, News
Ein implantologischer Eingriff birgt für Patientinnen und Patienten, die unter einer Blutgerinnungsstörung leiden bzw. blutgerinnungshemmende Medikamente einnehmen, besondere Risiken. In einem kommenden Webinar wird Dr. Stefan Grümer, Spezialist für Implantologie und Laserzahnheilkunde sowie Leiter der klinischen Ausbildung im Masterstudiengang Laser in der Zahnmedizin an der RWTH Aachen, einen neuen Behandlungsansatz vorstellen. Die neue Methode soll eine Erweiterung des Therapiespektrums für jene Patientinnen und Patienten bieten, für die eine konventionelle Implantation nicht geeignet ist.
January 15, 2021 | Events, Interviews, News
IRVINE, Calif., U.S.: The dental laser innovator BIOLASE has announced an agreement with Dental Care Alliance (DCA), one of the largest dental support organizations in the U.S. with more than 330 affiliated practices in 20 states. With this joint effort, they aim to expand laser adoption and hands-on training programs in targeted geographical areas.
October 29, 2020 | Events, Interviews, News
FOOTHILL RANCH, Calif., U.S.: Medical device company BIOLASE expects that its U.S. sales revenue for the third quarter of 2020 will be in line with that of the corresponding pre-COVID-19 period last year. The company’s sales fell sharply in the first half of this year, but its preliminary earnings announcement will bring a degree of optimism as a host of major dental companies prepare to release their third quarter earnings reports in the coming weeks.
WebinarsView All
Neuer Ansatz in der Implantattherapie von Patienten unter Antikoagulant-Medikation (DOAC)
Ziel des Webinars ist die bewusste Nutzung von Lasern zur Erweiterung des eigenen Therapiespektrums am Beispiel der Behandlung von Patienten unter NOAC bzw. DOAC-Therapie und den hieraus resultierenden zusätzlichen Nutzen für Patient und Praxis.
Laser applications in daily practice
This presentation focuses on the various clinical applications of the Er,Cr: YSGG laser in daily practice as well as the clinical and patient reported benefits provided by this technology.
ER,CR:YSGG LASER’S ROLE IN ROOT CANAL DISINFECTION
The webinar will discuss how the YSGG laser can achieve root canal disinfection and compare different techniques and protocols to choose the best way to treat endo patients.
Croatia / Hrvatska
UK & Ireland / UK & Ireland